Drug
Drug XS 03
Drug XS 03: highest development phase Phase 1/2, developed by Shanghai Fosun Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Shanghai Fosun Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| Drug: XS-03, Biological: Bevacizumab, Drug: FOLFOX, Drug: FOLFIRI NCT06936527 | Phase 1/2 | Colorectal Cancer |
Latest
No recent events.
Follow Drug XS 03 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.